Keywords: bioalliance, 3rd-qtr, income, grows, 9m, french, drugmaker

BioAlliance's 3rd-qtr income grows to $1.9M

Article | 10 November 2008

French drugmaker BioAlliance Pharma says that third-quarter 2008 sales of its first marketed product, the antifungal Loramyc (miconazole), amounted to 282,000 euros ($351,123), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Miconazole

Monistat-Derm

Go to drug listing